SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 61 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $32,464,000 | +93.3% | 12,213,000 | +32.6% | 0.14% | +101.4% |
| Q4 2014 | $16,796,000 | -14.0% | 9,213,000 | +14.1% | 0.07% | -12.3% |
| Q3 2014 | $19,539,000 | +2719.5% | 8,078,000 | -77.1% | 0.08% | +2600.0% |
| Q2 2014 | $693,000 | -0.4% | 35,309,000 | -14.2% | 0.00% | 0.0% |
| Q1 2014 | $696,000 | -98.8% | 41,159,000 | +3.4% | 0.00% | -98.8% |
| Q4 2013 | $59,331,000 | -40.2% | 39,803,000 | -50.8% | 0.25% | -1.6% |
| Q3 2013 | $99,158,000 | +96.8% | 80,822,000 | +91.4% | 0.26% | -5.1% |
| Q2 2013 | $50,376,000 | – | 42,222,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $4,916,000 | 4.33% |
| SYMPHONY ASSET MANAGEMENT LLC | 19,840,000 | $38,948,000 | 4.05% |
| SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $38,695,000 | 4.00% |
| MACKAY SHIELDS LLC | 31,471,000 | $61,916,000 | 3.41% |
| Sage Capital Management, LLC | 1,500,000 | $2,942,000 | 2.98% |
| ALTEGRIS ADVISORS, L.L.C. | 250,000 | $491,000 | 2.56% |
| Wellesley Asset Management | 16,220 | $31,923,000 | 2.01% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $16,883,000 | 1.62% |
| CAMDEN ASSET MANAGEMENT L P /CA | 13,862,000 | $27,213,000 | 1.58% |
| Calamos Wealth Management LLC | 2,061,000 | $4,045,000 | 1.15% |